In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer

Hydroxamic Acid ◽

Inhibitor Therapy ◽

Suberoylanilide Hydroxamic Acid, a Histone Deacetylase Inhibitor: Effects on Gene Expression and Growth of Glioma Cells In vitro and In vivo

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-1261 ◽

2007 ◽

Vol 13 (3) ◽

pp. 1045-1052 ◽

Cited By ~ 103

Author(s):

Dong Yin ◽

John M. Ong ◽

Jinwei Hu ◽

Julian C. Desmond ◽

Norihiko Kawamata ◽

...

Keyword(s):

Gene Expression ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Glioma Cells ◽

In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: Does timing matter?

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.06.030 ◽

2010 ◽

Vol 119 (2) ◽

pp. 351-357 ◽

Cited By ~ 17

Author(s):

Susan C. Modesitt ◽

Sarah J. Parsons

Keyword(s):

Ovarian Cancer ◽

Histone Deacetylase ◽

Inhibitor Therapy ◽

Cancer Models ◽

Synergistic activity of the histone deacetylase inhibitor suberoylanilide hydroxamic acid and the bisphosphonate zoledronic acid against prostate cancer cells in vitro

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-07-0221 ◽

2007 ◽

Vol 6 (11) ◽

pp. 2976-2984 ◽

Cited By ~ 22

Author(s):

Jürgen Sonnemann ◽

Beata Bumbul ◽

James F. Beck

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Synergistic Activity ◽

Prostate Cancer Cells ◽

In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model

Radiation Oncology ◽

10.1186/1748-717x-7-52 ◽

2012 ◽

Vol 7 (1) ◽

pp. 52 ◽

Cited By ~ 18

Author(s):

Markus Thiemann ◽

Susanne Oertel ◽

Volker Ehemann ◽

Wilko Weichert ◽

Albrecht Stenzinger ◽

...

Keyword(s):

Mouse Model ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Malignant Rhabdoid Tumor ◽

In Vivo Efficacy ◽

Deacetylase Inhibitor ◽

Tumor Mouse Model

In vivo redox state of Human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)

Free Radical Biology and Medicine ◽

10.1016/j.freeradbiomed.2012.09.019 ◽

2012 ◽

Vol 53 (11) ◽

pp. 2002-2007 ◽

Cited By ~ 23

Author(s):

J. Ungerstedt ◽

Y. Du ◽

H. Zhang ◽

D. Nair ◽

A. Holmgren

Keyword(s):

Histone Deacetylase ◽

Hydroxamic Acid ◽

Redox State ◽

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells

International Journal of Cancer ◽

10.1002/ijc.22558 ◽

2007 ◽

Vol 121 (3) ◽

pp. 656-665 ◽

Cited By ~ 123

Author(s):

Takashi Kumagai ◽

Naoki Wakimoto ◽

Dong Yin ◽

Sigal Gery ◽

Norihiko Kawamata ◽

...

Keyword(s):

Pancreatic Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Human Pancreatic Cancer ◽

Pancreatic Cancer Cells ◽

CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-06-0042 ◽

2006 ◽

Vol 5 (7) ◽

pp. 1693-1701 ◽

Cited By ~ 19

Author(s):

Z. Alexander Cao ◽

Kathryn E. Bass ◽

Sriram Balasubramanian ◽

Liang Liu ◽

Brian Schultz ◽

...

Keyword(s):

Histone Deacetylase ◽

Broad Spectrum ◽

Antiangiogenic Activity ◽

Treatment of canine haemangiosarcoma with suberoylanilide hydroxamic acid, a histone deacetylase inhibitor

Veterinary and Comparative Oncology ◽

10.1111/j.1476-5810.2004.00057.x ◽

2004 ◽

Vol 2 (4) ◽

pp. 243-248 ◽

Cited By ~ 12

Author(s):

L. A. Cohen ◽

B. Powers ◽

S. Amin ◽

D. Desai

Keyword(s):

Histone Deacetylase ◽

Hydroxamic Acid ◽

Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo

Journal of Hepatology ◽

10.1016/j.jhep.2011.07.013 ◽

2012 ◽

Vol 56 (1) ◽

pp. 176-183 ◽

Cited By ~ 32

Author(s):

Huanjie Shao ◽

Chun Gao ◽

Haikuo Tang ◽

Hao Zhang ◽

Lewis R. Roberts ◽

...

Keyword(s):

Histone Deacetylase ◽

Dual Targeting ◽

Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo

Biochemical Pharmacology ◽

10.1016/s0006-2952(02)01261-3 ◽

2002 ◽

Vol 64 (7) ◽

pp. 1079-1090 ◽

Cited By ~ 63

Author(s):

Yuka Sasakawa ◽

Yoshinori Naoe ◽

Takeshi Inoue ◽

Tatsuya Sasakawa ◽

Masahiko Matsuo ◽

...

Keyword(s):

Histone Deacetylase ◽

Deacetylase Inhibitor ◽

Human Lymphoma